Entrada Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $16M | 1.1M | 14.25 |
| 2024-03-31 | $15M | 1.1M | 14.17 |
| 2023-12-31 | $16M | 1.1M | 15.09 |
| 2023-09-30 | $16M | 1.0M | 15.80 |
| 2023-06-30 | $15M | 1.0M | 15.14 |
| 2023-03-31 | $14M | 929k | 14.50 |
| 2022-12-31 | $12M | 920k | 13.52 |
| 2022-06-30 | $9.3M | 762k | 12.18 |
| 2022-03-31 | $4.0M | 430k | 9.39 |